Clinical trial

CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients…

NCT00170313 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Terminated

Key facts

NCT number NCT00170313
Title CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation
Official title Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)
Lead sponsor Medtronic Cardiac Rhythm and Heart Failure, Industry
Collaborators Medtronic Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Heart Failure, Sudden Cardiac Death, Atrial Fibrillation
Intervention type Device
Interventions Conducted AF-Response Algorithm (CAFR) On, Conducted AF-Response Algorithm (CAFR) Off
Enrollment 100
Start date Dec 1, 2003
Completion Jan 1, 2007
First posted Sep 15, 2005
Last update posted Jul 3, 2025
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies